A novel in vitro enzyme-linked immunosorbent spot (ELISPOT) assay has been described, which measures cellular in vitro responses to ABC and might be useful to further characterize suspected ABC HSR risk in peripheral blood mononuclear cells from subjects who lack the HLA-B*57:01 allele [27]. This evidence concerns the gene HLA-B and aneurysmal bone cyst.